Your browser doesn't support javascript.
loading
Luciferase- and HaloTag-based reporter assays to measure small-molecule-induced degradation pathway in living cells.
Schwalm, Martin P; Saxena, Krishna; Müller, Susanne; Knapp, Stefan.
Afiliação
  • Schwalm MP; Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany. schwalm@pharmchem.uni-frankfurt.de.
  • Saxena K; Structural Genomics Consortium (SGC), Buchmann Institute for Life Sciences, Frankfurt am Main, Germany. schwalm@pharmchem.uni-frankfurt.de.
  • Müller S; German Cancer Consortium (DKTK)/German Cancer Research Center (DKFZ), DTKT Site Frankfurt-Mainz, Heidelberg, Germany. schwalm@pharmchem.uni-frankfurt.de.
  • Knapp S; Institute for Pharmaceutical Chemistry, Johann Wolfgang Goethe-University, Frankfurt am Main, Germany.
Nat Protoc ; 19(8): 2317-2357, 2024 Aug.
Article em En | MEDLINE | ID: mdl-38637703
ABSTRACT
The rational development of small-molecule degraders (e.g., proteolysis targeting chimeras) remains a challenge as the rate-limiting steps that determine degrader efficiency are largely unknown. Standard methods in the field of targeted protein degradation mostly rely on classical, low-throughput endpoint assays such as western blots or quantitative proteomics. Here we applied NanoLuciferase- and HaloTag-based screening technologies to determine the kinetics and stability of small-molecule-induced ternary complex formation between a protein of interest and a selected E3 ligase. A collection of live-cell assays were designed to probe the most critical steps of the degradation process while minimizing the number of required expression constructs, making the proposed assay pipeline flexible and adaptable to the requirements of the users. This approach evaluates the underlying mechanism of selective target degraders and reveals the exact characteristics of the developed degrader molecules in living cells. The protocol allows scientists trained in basic cell culture and molecular biology to carry out small-molecule proximity-inducer screening via tracking of the ternary complex formation within 2 weeks of establishment, while degrader screening using the HiBiT system requires a CRISPR-Cas9 engineered cell line whose generation can take up to 3 months. After cell-line generation, degrader screening and validation can be carried out in high-throughput manner within days.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteólise / Luciferases Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteólise / Luciferases Limite: Humans Idioma: En Ano de publicação: 2024 Tipo de documento: Article